tiprankstipranks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab Updates Articles of Association, Expands Capital-Raising Flexibility
Company AnnouncementsGenmab Updates Articles of Association, Expands Capital-Raising Flexibility
6d ago
6K
GMAB
Genmab: Buy Rating Backed by Pivotal Epkinly Data Conviction and Blockbuster Potential Across Key Oncology Programs
PremiumRatings
Genmab: Buy Rating Backed by Pivotal Epkinly Data Conviction and Blockbuster Potential Across Key Oncology Programs
7d ago
GMAB
Genmab Boosts Share Capital After Employee Warrant Exercise
PremiumCompany Announcements
Genmab Boosts Share Capital After Employee Warrant Exercise
7d ago
6K
GMAB
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
PremiumMarket News
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
8d ago
GMAB
RPRX
Genmab price target raised to $35 from $33 at Morgan Stanley
PremiumThe Fly
Genmab price target raised to $35 from $33 at Morgan Stanley
11d ago
GMAB
Genmab price target raised to $42 from $40 at Guggenheim
PremiumThe FlyGenmab price target raised to $42 from $40 at Guggenheim
11d ago
GMAB
Genmab: Buy Rating Backed by Epkinly Outperformance and $8 Billion Peak-Sales Pipeline Potential
Premium
Ratings
Genmab: Buy Rating Backed by Epkinly Outperformance and $8 Billion Peak-Sales Pipeline Potential
12d ago
GMAB
Genmab’s Earnings Call Highlights Growth, Upgraded Outlook
Premium
Company Announcements
Genmab’s Earnings Call Highlights Growth, Upgraded Outlook
12d ago
GMAB
Genmab Lifts 2026 Outlook on Strong H1 Results and Positive Epcoritamab Data
PremiumCompany Announcements
Genmab Lifts 2026 Outlook on Strong H1 Results and Positive Epcoritamab Data
12d ago
6K
GMAB
Genmab reports Q2 revenue $1.155B vs. $925M last year
PremiumThe Fly
Genmab reports Q2 revenue $1.155B vs. $925M last year
12d ago
GMAB
Genmab raises FY26 revenue view to $4.325B-$4.525B from $4.065B-$4.395B
PremiumThe Fly
Genmab raises FY26 revenue view to $4.325B-$4.525B from $4.065B-$4.395B
12d ago
GMAB
Genmab Opens New Front in Solid Tumor Battle With GEN1119 Phase 1 Trial
PremiumCompany Announcements
Genmab Opens New Front in Solid Tumor Battle With GEN1119 Phase 1 Trial
14d ago
GMAB
Genmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet
PremiumCompany AnnouncementsGenmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet
25d ago
GMAB
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
Premium
The Fly
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
26d ago
ABBV
GMAB
Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors
Premium
Company Announcements
Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors
27d ago
GMAB
CoreWeave upgraded, IBM initiated: Wall Street’s top analyst calls
PremiumThe Fly
CoreWeave upgraded, IBM initiated: Wall Street’s top analyst calls
27d ago
PM
BKH
Genmab upgraded to Buy from Hold at TD Cowen
PremiumThe Fly
Genmab upgraded to Buy from Hold at TD Cowen
27d ago
GMAB
Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
PremiumCompany Announcements
Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
29d ago
GMAB
Genmab reports Q2 net sales of Darzalex $4.207B
PremiumThe Fly
Genmab reports Q2 net sales of Darzalex $4.207B
1M ago
JNJ
GMAB
Buy Rating Reiterated on Genmab as DARZALEX Franchise Seen Defensible; $40 Price Target Maintained
PremiumRatingsBuy Rating Reiterated on Genmab as DARZALEX Franchise Seen Defensible; $40 Price Target Maintained
1M ago
GMAB
Genmab says EC grants marketing authorization for Tepkinly combo
Premium
The Fly
Genmab says EC grants marketing authorization for Tepkinly combo
1M ago
ABBV
GMAB
Genmab price target raised to $40 from $38 at H.C. Wainwright
Premium
The Fly
Genmab price target raised to $40 from $38 at H.C. Wainwright
2M ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >